Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dynamic Biotechnology & Genome Invesco ETF (PBE)

Dynamic Biotechnology & Genome Invesco ETF (PBE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 339,836,000
  • Shares Outstanding, K 4,580
  • 60-Month Beta 1.08
Trade PBE with:
  • Price/Earnings ttm 51.90
  • Annual Dividend & Yield 0.03
  • Most Recent Dividend 0.029
  • Management Fee 0.58%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.57 +4.88%
on 02/26/21
84.86 -10.31%
on 02/09/21
-2.34 (-2.98%)
since 02/01/21
3-Month
64.15 +18.64%
on 12/03/20
84.86 -10.31%
on 02/09/21
+11.30 (+17.43%)
since 12/01/20
52-Week
38.08 +99.86%
on 03/18/20
84.86 -10.31%
on 02/09/21
+26.00 (+51.90%)
since 02/28/20

Most Recent Stories

More News
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 33.69 (+0.60%)
MRNA : 157.40 (+1.67%)
LLY : 206.47 (+0.77%)
IBB : 159.65 (+1.73%)
CNCR : 32.51 (+3.14%)
XBI : 151.60 (+2.43%)
BBH : 180.96 (+1.10%)
FBT : 170.05 (+1.10%)
SBIO : 56.60 (+2.59%)
PBE : 76.11 (+2.62%)
BTEC : 64.24 (+2.82%)
ARKG : 97.79 (+4.58%)
BNTX : 110.21 (+1.08%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 76.11 (+2.62%)
BIIB : 273.24 (+0.13%)
QGEN : 50.36 (+0.72%)
IBB : 159.65 (+1.73%)
PACB : 35.22 (+15.21%)
XBI : 151.60 (+2.43%)
ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

ALXN : 151.97 (-0.51%)
AZN : 48.09 (-0.60%)
PPH : 67.98 (+0.67%)
BBH : 180.96 (+1.10%)
FBT : 170.05 (+1.10%)
PJP : 77.39 (+0.99%)
PBE : 76.11 (+2.62%)
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 76.11 (+2.62%)
BIIB : 273.24 (+0.13%)
QGEN : 50.36 (+0.72%)
IBB : 159.65 (+1.73%)
PACB : 35.22 (+15.21%)
XBI : 151.60 (+2.43%)
ETFs That Gained the Most in One of Best Post-Election Rallies

Wall Street booked remarkable gains a day after the election on hopes of a divided Congress.

XBI : 151.60 (+2.43%)
EMQQ : 73.61 (+3.97%)
IPO : 69.40 (+3.91%)
PBE : 76.11 (+2.62%)
KWEB : 93.47 (+4.10%)
RWGV : 103.25 (+2.42%)
WCLD : 55.30 (+4.05%)
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 76.11 (+2.62%)
BIIB : 273.24 (+0.13%)
QGEN : 50.36 (+0.72%)
IBB : 159.65 (+1.73%)
PACB : 35.22 (+15.21%)
XBI : 151.60 (+2.43%)
ETFs in Focus on Bayer's Bet on Gene Therapy

Bayer has made a big bet on gene therapy by announcing the acquisition of U.S. biotech firm Asklepios BioPharmaceutical for as much as $4 billion.

PBE : 76.11 (+2.62%)
ARKG : 97.79 (+4.58%)
GNOM : 24.94 (+4.44%)
IDNA : 48.53 (+3.23%)
Biotech ETFs to Shine on Coronavirus Antibodies Progress

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

IBB : 159.65 (+1.73%)
XBI : 151.60 (+2.43%)
BBH : 180.96 (+1.10%)
PBE : 76.11 (+2.62%)
ARKG : 97.79 (+4.58%)
Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

PBE : 76.11 (+2.62%)
ARKG : 97.79 (+4.58%)
GNOM : 24.94 (+4.44%)
IDNA : 48.53 (+3.23%)
Biotech ETFs to Gain on Trump's COVID-19 Treatment Protocol

The progress in Trump's health condition and his treatment protocols are continuously under the purview of market participants and are impacting Wall Street movements.

IBB : 159.65 (+1.73%)
XBI : 151.60 (+2.43%)
BBH : 180.96 (+1.10%)
PBE : 76.11 (+2.62%)
ARKG : 97.79 (+4.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Invesco Dynamic Biotechnology and Genome ETF is based on the Dynamic Biotech and Genome Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating...

See More

Key Turning Points

3rd Resistance Point 77.64
2nd Resistance Point 77.24
1st Resistance Point 76.68
Last Price 76.11
1st Support Level 75.72
2nd Support Level 75.32
3rd Support Level 74.76

See More

52-Week High 84.86
Last Price 76.11
Fibonacci 61.8% 66.99
Fibonacci 50% 61.47
Fibonacci 38.2% 55.95
52-Week Low 38.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar